[Photo] Yoonjung Park, Chief Technology Officer of Nivac, “The Potential of GLP-1 in Treating CNS Disorders and Industry Response Strategies” View original image

Yoonjung Park, Chief Technology Officer of Nivac, is giving a lecture on the theme "The Potential of GLP-1 in Treating CNS Disorders and Industry Response Strategies" at the "2026 Good Brain Conference," held under the theme "Brain Revolution: How GLP-1 Will Change the Future of Humanity" at the Orchid Room, Westin Josun Hotel in Jung-gu, Seoul, on September 3, 2026.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing